Changing perspectives: unveiling the risks of ashwagandha-induced hepatotoxicity
Casiano-Manzano S, Torres-Larrubia M, Masa-Caballero A, Jiménez-Colmenarez Z, Martín-Noguerol E, Fernández-Bermejo M, Solís-Muñoz P
Revista espanola de enfermedades digestivas · 2 citations
Review labels
Neutral facts our review recorded about how this study was done. They describe method, never whether we like the result.
How it was studied
- Design
- Case report (indexed by PubMed)
- Studied in
- People
- Main outcome
- Clinical events such as disease or death
Who paid for it
- Funding
- Funding not disclosed
Publication
- Published
- 2023-01-01 · Rev Esp Enferm Dig · vol. 117 · issue 5 · pp. 288–289
- Publisher
- Arán Ediciones
- Cited
- 5 citations · more than 76% of similar papers · 1.0× the field average
- References
- 5 works
- Access
- Paywalled
- Research areas
- Drug-Induced Hepatotoxicity and Protection · Complementary and Alternative Medicine Studies · Pesticide Exposure and Toxicity
- Keywords
- Medicine, Alternative medicine, Traditional medicine, Intensive care medicine, Medicinal herbs, Liver damage, Pathology, Internal medicine
- MeSH
- humans, withania, plant extracts, medicine, ayurvedic, middle aged, male, chemical and drug induced liver injury
7 authors
From ES
- Sergio Casiano-ManzanoComplejo Hospitalario de Cáceres
- Macarena Torres-LarrubiaComplejo Hospitalario de Cáceres
- Alberto Masa-CaballeroComplejo Hospitalario de Cáceres
- Zuliani Jiménez-ColmenarezComplejo Hospitalario de Cáceres
- Elisa Martín-NoguerolComplejo Hospitalario de Cáceres
- Miguel Fernández‐BermejoComplejo Hospitalario de Cáceres
Abstract
Ashwagandha, an herb popular in Ayurvedic medicine, is renowned for its health-enhancing properties. However, its association with liver damage in recent years has raised significant concerns, necessitating careful assessment and management. This case underscores the dangers of Ashwagandha, particularly for individuals with preexisting liver conditions, where it can lead to life-threatening acute-on-chronic liver failure. The lack of solid clinical evidence supporting Ashwagandha's health claims emphasizes the need for an evidence-based approach. Public education is essential to raise awareness of the risks associated with herbal supplements and prevent liver diseases.
Abstract via Europe PMC. Copyright remains with the authors or publisher.
Community trust
Loading…
How much do you trust this study's findings?
Comments
Sign in to rate, comment on or flag this study.Sign inSomething wrong here?
Flag this study if its information, labels or funding look wrong. An editor reviews every flag.
Sign in to rate, comment on or flag this study.Sign inEducational information about published research. Not medical advice, and not a recommendation to start or stop anything.